Author:
Kobayashi Takashi,Ohta Yoshiji,Yoshino Junji,Nakazawa Saburo
Reference52 articles.
1. Gastric cytoprotection by tetraprenylacetone in human subjects;Arakawa;Digestion,1988
2. Effects of teprenone in gastric mucosal lesions as complications of chronic liver diseases. Studies of changes in gastric mucosal hexosamine, Helicobacter pylori and plasma polymorphonuclear leukocyte elastase complex;Nakata;Gastroenterology (Tokyo),1994
3. Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: A nationwide, multicenter clinical study;Shirakabe;Clin Ther,1995
4. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells;Terano;Digestion,1986
5. Geranylgeranylacetone, an anti-ulcer drug, stimulates hexosamine production in a rat mucosal cell line through binding to a specific cytosolic protein;Hassan;J Gastroenterol Hepatol,1998
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献